Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Mol Cell Cardiol. 2018 Feb 21;117:62–71. doi: 10.1016/j.yjmcc.2018.02.011

Fig. 3.

Fig. 3

TM treatment altered (A) the morphology of the action potential with (B) prolonged action potential duration (APD90) and decreased dV/dtmax of hiPSC-CMs. TM treatment downregulated (C) all major cardiac ion channel currents and positively shifted (D) the V1/2 value of INa steady state activation. Up to 30 cells were used for data average for each group. *P<0.05 vs the untreated group.